12 completed. 12 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 12 |
| Phase 3 | 2 | Completed 2 |
Follow Pemphigus: new trials by email Literature Review of Pemphigus trials Research Report on Pemphigus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Topical Insulin on Healing Rate of Pemphigus Lesions insulin glargine, human insulin, 0.9% Normal Saline - Pemphigus Vulgaris, Skin Erosion | Phase 2 | Completed | Alexandria University | 20 | 2024-06-22 | 2026-03-10 |
| Dexamethasone Solution and Dexamethasone in Mucolox™ dexamethasone 0.5mg/5ml solution, dexamethasone 0.5mg/5ml solution in Mucolox™ - Oral Lichen Planus, Mucous Membrane Pemphigoid | Phase 2 | Completed | University of California, San Francisco | 29 | 2020-12-26 | 2023-12-15 |
| A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus ARGX-113 - Pemphigus Vulgaris, Pemphigus Foliaceus | Phase 2 | Completed | argenx | 34 | 2017-10-18 | 2020-12-14 |
| A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris PRN1008 - Pemphigus Vulgaris | Phase 2 | Completed | Principia Biopharma, a Sanofi Company | 42 | 2016-01-22 | 2023-02-13 |
| Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine - Pemphigus | Phase 2 | Completed | University of Luebeck | 23 | 2008-01-01 | 2017-03-13 |
| Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone Azathioprine, Prednisone, Placebo - Pemphigus Vulgaris | Phase 2 | Completed | Tehran University of Medical Sciences | 48 | 2008-01-01 | 2010-11-30 |
| Use of KC706 for the Treatment of Pemphigus Vulgaris KC706 - Pemphigus Vulgaris | Phase 2 | Completed | Kemia, Inc | 20 | 2007-11-01 | 2008-06-19 |
| Use of Infliximab for the Treatment of Pemphigus Vulgaris Infliximab, Placebo Comparator - Pemphigus | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2006-03-01 | 2017-12-06 |
| Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris Enbrel (Etanercept) - Pemphigus Vulgaris | Phase 2 | Completed | Massachusetts General Hospital | 12 | 2004-06-01 | 2015-06-03 |
| Effect of Anti CD20 in Pemphigus Desease Mabthera - Pemphigus | Phase 2 / Phase 3 | Completed | University Hospital, Rouen | 22 | 2003-06-01 | 2013-06-18 |
| European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus dexamethasone (50mg 1dd6, 3 consecutive days/month) - Pemphigus | Phase 2 / Phase 3 | Completed | University Medical Center Groningen | 60 | 2001-01-01 | 2007-08-30 |
| Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus cyclophosphamide, filgrastim - Pemphigus | Phase 2 | Completed | Johns Hopkins University | 35 | 1999-04-01 | 2008-10-02 |
Autoimmune Diseases (1) · Bronchiolitis Obliterans Syndrome (1) · Communicable Diseases (1) · Immune System Diseases (1) · Insulin Resistance (1) · Lichen Planus, Oral (1) · Pemphigoid, Benign Mucous Membrane (1) · Rare Diseases (1) · Skin Diseases (1)
Skin Diseases, Vesiculobullous (12) · Skin and Connective Tissue Diseases (12) · Autoimmune Diseases (11) · Immune System Diseases (11) · Skin Diseases (11) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Conjunctival Diseases (1) · Disease Attributes (1) · Eye Diseases (1) · Glucose Metabolism Disorders (1) · Graft vs Host Disease (1) · Hyperinsulinism (1)
Dexamethasone (3) · Azathioprine (2) · Rituximab (2) · Cyclophosphamide (1) · Etanercept (1) · Filgrastim (1) · Infliximab (1) · Insulin (1) · Insulin Glargine (1) · Prednisone (1) · Saline Solution (1) · Solutions (1) · efgartigimod alfa (1)
Alexandria University (1) · Johns Hopkins University (1) · Kemia, Inc (1) · Massachusetts General Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Principia Biopharma, a Sanofi Company (1) · Tehran University of Medical Sciences (1) · University Hospital, Rouen (1) · University Medical Center Groningen (1) · University of California, San Francisco (1) · University of Luebeck (1) · argenx (1)
United States (5) · France (2) · Germany (2) · Israel (2) · Australia (1) · Croatia (1) · Egypt (1) · Greece (1) · Hungary (1) · Iran (1) · Italy (1) · Netherlands (1) · Ukraine (1)
Victoria Werth, MD (2) · Alessandro Villa, DDS, PhD, MPH (1) · Alexandra B Kimball, MD, MPH (1) · Amit Pandya, MD (1) · Bruce Strober, MD (1) · Carmen I Farid, MB BCh, MD (1) · Cheyda Chams-Davatchi, MD (1) · David Rubenstein, MD, PhD (1) · David Woodley, MD (1) · Detlef Zillikens, MD (1) · E. William St. Clair, MD (1) · Francisco Kerdel, MD (1) · Garnett Kelsoe, DSci (1) · Grant J. Anhalt (1)
PMID 16702494, PMID 17687130, PMID 25123295, PMID 34608631, PMID 35663943, PMID 37549933
2015 (1), 2017 (1)